Megan Slade

Epic Sciences (United States) — United States

Medicine · Health Sciences

5h-index158citations21works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(9), Cancer Genomics and Diagnostics(6), PARP inhibition in cancer therapy(5), Prostate Cancer Treatment and Research(3), Cancer Immunotherapy and Biomarkers(2)

Publications21 total

643eP The association of circulating tumor cells with body mass index, body composition and blood biomarkers in patients with newly diagnosed metastatic breast cancer
Annals of Oncology·2025
A novel liquid biopsy assay for detection of ERBB2 (HER2) amplification in circulating tumor cells (CTCs)
Journal of Circulating Biomarkers·2024· 5 citedOpen Access
Circulating tumor cells enumeration and characterization in patients with lung cancer treated with immunotherapy.
Journal of Clinical Oncology·2024
Abstract PO5-04-04: Development of a method to detect very low levels of HER2 expression in Circulating Tumor Cells (CTCs) by liquid biopsy in patients with metastatic breast cancer
Cancer Research·2024
Abstract PO3-14-10: A single-center prospective cohort study to evaluate circulating tumor cells as a monitoring tool in women with breast cancer treated with neoadjuvant chemotherapy: final results of baseline data
Cancer Research·2024
Abstract PO4-15-01: A multi-center prospective cohort study to evaluate the presence of circulating tumor cells using the Epic Sciences platform among women with metastatic breast cancer
Cancer Research·2024
Abstract PO5-04-05: Clinical validation of the concordance performance of ERBB2 status by single-cells genomics ERBB2 (HER2) amplification Assay in Circulating Tumor Cells (CTCs) from patients with matched HER2 status from metastatic tissue biopsies
Cancer Research·2024
Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.
Journal of Clinical Oncology·2023· 3 cited
Concordance between liquid and tissue biopsy in participants with newly diagnosed recurrent breast cancer.
Journal of Clinical Oncology·2023· 1 cited
Supplementary Methods, Supplementary Table 1, and Supplementary Figures 1-4 from SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
2023Open Access
Data from SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
2023Open Access
Data from SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
2023Open Access
Supplementary Methods, Supplementary Table 1, and Supplementary Figures 1-4 from SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
2023Open Access
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma
JCO Precision Oncology·2022· 12 citedOpen Access
Author Correction: Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
npj Precision Oncology·2021Open Access
Circulating tumor cell heterogeneity in neuroendocrine prostate cancer by single cell copy number analysis
npj Precision Oncology·2021· 33 citedOpen Access
SLFN11 Expression in Advanced Prostate Cancer and Response to Platinum-based Chemotherapy
Molecular Cancer Therapeutics·2020· 67 citedOpen Access
117 Establishing a mesothelioma support group
Lung Cancer·2012
Predictors of Hypertension and Heart Disease Among White- and Blue-Collar Employees: Alcoa Aluminum Manufacturing Cohort
Epidemiology·2007· 1 cited
DOXORUBICIN AND BOOP. A POSSIBLE NEAR FATAL ASSOCIATION
Clinical Oncology·2002· 35 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Rick Wenstrup(9), Vincenza Conteduca(7), Sheng‐Yu Ku(7), Luisa Fernandez(7), Michael Sigouros(7), Juan Miguel Mosquera(7), Ryan Dittamore(7), Himisha Beltran(7), Giuseppe Di(6), Loredana Puca(5), Judy Hess(5), Rohan Bareja(5), Panagiotis J. Vlachostergios(5), Andrea Sboner(5), David M. Nanus(5), Olivier Elemento(5), Scott T. Tagawa(5), Lee S. Schwartzberg(4), Ana Elisa Lohmann(4), Katarzyna J. Jerzak(4)